Early intervention with high-efficacy disease-modifying therapy (HE DMT) may be the best
strategy to delay irreversible neurological damage and progression of multiple sclerosis …

Multiple sclerosis (MS) is a chronic neurological disease that causes substantial health
economic impacts, however, the cost of informal care for MS is often excluded from health …

Secondary progressive multiple sclerosis (SPMS) is a debilitating condition characterized by
gradual worsening after an initial relapsing disease course. Despite the recent advances in …

Background Introduction of disease modifying treatment may have increased the cancer
incidence in multiple sclerosis patients. Our aim was to estimate the incidence of any cancer …

Given the importance of inflammation at the onset of multiple sclerosis (MS), therapy is
mainly based on the use of anti-inflammatory drugs including disease modifying therapies …

Introduction Multiple sclerosis (MS) is a progressive, chronic inflammatory demyelinating
disease of the central nervous system, whose symptoms include sexual disorders. Sexual …

In this study, rat models of wound closure by first and second intention were developed to
evaluate the influence that two immunosuppressants for treating multiple sclerosis …

Background Patients with multiple sclerosis (MS) experience disabilities which significantly
affect their quality of life (QOL) and mental health. Mood disorders and depressive symptoms …

The aim of the current review is to summarize the results of studies on the role of γδ T cells in
the pathogenesis of multiple sclerosis and its animal model–the experimental autoimmune …

Sažetak Introduction: Disease-modifying therapy (DMT) dramatically influenced the
management of re-lapsing-remitting multiple sclerosis (RRMS). Novel medicines have been …